Compare
Cardinal Health vs Lilly (Eli) (CAH vs LLY)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Cardinal Health (CAH) returned +38.1% and Lilly (Eli) (LLY) +46.2%; so far this year the figures are +32.2% and +26.0%.
Lilly (Eli) is the larger company by market value, about 20.3 times the size of Cardinal Health.
On trailing earnings, CAH trades at 37.6 times and LLY at 43.9 times.
Revenue grew +14.2% at CAH and +45.5% at LLY over the last year.
CAH yields 0.57%. LLY yields 0.49%.
Data as of the latest close. Not investment advice.
Relative performance
| CAH | LLY | |
|---|---|---|
| Price | $271.72 | $1,354.00 |
| 1-day | +1.46% | -0.79% |
| YTD | +32.22% | +25.99% |
| 1 year | +38.08% | +46.25% |
| 3 years | +190.36% | +144.20% |
| Market cap | $62.8B | $1.27T |
| P/E | 37.6 | 43.9 |
| P/S | 0.25 | 14.73 |
| P/B | — | 31.63 |
| Revenue growth | +14.20% | +45.50% |
| EPS growth | — | +50.70% |
| Gross margin % | 3.8 | 83.6 |
| Net margin % | 0.7 | 31.9 |
| ROE % | — | 68.5 |
| Debt / equity | — | 1.23 |
| FCF yield % | 7.2 | 2.4 |
| Dividend yield % | 0.57 | 0.49 |
| Beta | -0.02 | 0.29 |
| RSI (14) | 73.8 | 61.1 |
| Technical rating |